Stock comparison
Side-by-side financials for CTKB and AVTR. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AVTR is larger
Market cap data is available for the leading company in this comparison.
Market value leader
AVTR
Latest market capitalization comparison.
Revenue leader
AVTR
CTKB: $201.49M vs AVTR: $6.55B.
Profit leader
CTKB
CTKB: -$66.54M vs AVTR: -$530.20M.
Margin leader
AVTR
CTKB: -33.0% vs AVTR: -8.1% net margin.
| Metric | CTKB | AVTR |
|---|---|---|
| Market cap | - | $10.16 B |
| US-listed rank | - | #935 |
| Revenue (latest FY) | $201.49M | $6.55B |
| Net income (latest FY) | -$66.54M | -$530.20M |
| Net margin | -33.0% | -8.1% |
| P/E (trailing FY) | - | - |
| SEC filings | 432 | 763 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, Cytek Biosciences, Inc. reported $201.49M in revenue while Avantor, Inc. reported $6.55B.
Full pages: Cytek Biosciences, Inc. and Avantor, Inc., or browse the full rankings.